Index of reports
> Cases with Weight Decreased (8)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Scopolamine where reactions include weight decreased. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Scopolamine side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-28
Patient: female, weighing 70.0 kg (154.0 pounds)
Reactions: Weight Decreased, Drug Ineffective, Pain, Mental Status Changes, Constipation, Gastric Ulcer, Hypokalaemia, Malignant Pleural Effusion, Oedema Peripheral, Depression, Acute Respiratory Failure, Gastrooesophageal Reflux Disease, Anaemia Postoperative, Cough, Vomiting, Dyspnoea, Nausea, Anaemia, Catatonia, Anxiety, Acute Sinusitis, Diarrhoea, Neoplasm Malignant, Dehydration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Scopolamine
Indication: Vomiting
Marinol
Indication: Vomiting
Dasatinib
Dosage: 20 mg, uid/qd
Administration route: Oral
Start date: 2011-12-02
End date: 2012-03-04
Dasatinib
Dosage: 50 mg, uid/qd
Administration route: Oral
Reglan
Dosage: 5 mg, bid
Administration route: Oral
Indication: Nausea
Phenergan HCL
Indication: Vomiting
Klonopin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Dasatinib
Dosage: 20 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2011-12-02
End date: 2012-01-06
Dasatinib
Dosage: 50 mg, uid/qd
Administration route: Oral
Start date: 2011-12-02
End date: 2012-01-06
Marinol
Dosage: 2.5 mg, bid
Administration route: Oral
Indication: Nausea
Scopolamine
Dosage: 1 df, q72hrs
Administration route: Topical
Indication: Nausea
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Start date: 2012-01-20
End date: 2012-03-04
Erlotinib Hydrochloride
Dosage: 150 mg, uid/qd
Administration route: Oral
Indication: non-Small Cell Lung Cancer Metastatic
Start date: 2011-12-02
End date: 2012-01-06
Dasatinib
Dosage: 50 mg, uid/qd
Administration route: Oral
Start date: 2012-01-20
End date: 2012-03-04
Reglan
Indication: Vomiting
Phenergan HCL
Dosage: 75 mg, q8 hours prn
Indication: Nausea
Other drugs received by patient: Lomotil; Calcium Carbonate; Zofran; Colestipol Hydrochloride; Hydrochlorothiazide; Fish OIL; Tylenol; Metoprolol Succinate; Lomotil; Effexor XR; Diovan; Ondansetron HCL; Tylenol; Toprol-XL; Timolol Maleate; Simvastatin; Evista; Norvasc; Clonazepam; Calcium +D; Zetia; Xalatan; Prevacid; Aspirin; Ondansetron HCL; Dronabinol
Possible Scopolamine side effects in female
Reported by a physician from United States on 2012-01-29
Patient: female, weighing 57.2 kg (125.8 pounds)
Reactions: Aphagia, Weight Decreased, Vomiting, Drug Ineffective, Drug Hypersensitivity, Crohn's Disease, Abasia, Pain, Application Site Pain, Local Swelling, Eczema, Anxiety, Neuropathy Peripheral, Laboratory Test Abnormal, Fibromyalgia, Sepsis, Depression
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Humira
Indication: Crohn's Disease
Scopolamine
Indication: Vomiting
Start date: 2011-01-01
End date: 2011-01-01
Pain Medication
Indication: Pain
Humira
Start date: 2011-05-01
End date: 2011-06-01
Other drugs received by patient: Fentanyl; Lyrica; Cimzia; Ondansetron HCL; Klonopin; Tramadol HCL; Oxycodone HCL; Phenergan; Cymbalta
Possible Scopolamine side effects in 44 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-03
Patient: 44 year old male, weighing 74.4 kg (163.7 pounds)
Reactions: Weight Decreased, White Blood Cell Count Decreased, Persecutory Delusion, Vomiting, Hallucination, Auditory, Mean Cell Volume Decreased, Microcytic Anaemia, Seasonal Allergy, RED Blood Cell Elliptocytes Present, Ideas of Reference, Platelet Count Decreased, Dizziness, Neutropenia, Salivary Hypersecretion
Drug(s) suspected as cause:
Clozaril
Dosage: 400 mg, unknown
Administration route: Oral
Scopolamine
Dosage: 10 mg, unk
Administration route: Oral
Indication: Irritable Bowel Syndrome
End date: 2011-05-20
Clozaril
Dosage: 375 mg, unknown
Administration route: Oral
End date: 2011-05-20
Clozaril
Dosage: unk
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-08-09
Risperidone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Hyoscine Hydrobromide; Ferrous Sulphate / 00023503 /; Sertraline Hydrochloride
Possible Scopolamine side effects in 44 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-02
Patient: 44 year old male, weighing 74.4 kg (163.7 pounds)
Reactions: White Blood Cell Count Decreased, Weight Decreased, Persecutory Delusion, Vomiting, Hallucination, Auditory, Mean Cell Volume Decreased, Microcytic Anaemia, RED Blood Cell Elliptocytes Present, Seasonal Allergy, Ideas of Reference, Dizziness, Platelet Count Decreased, Neutropenia, Salivary Hypersecretion
Drug(s) suspected as cause:
Clozaril
Dosage: unk
Administration route: Oral
End date: 2011-05-20
Scopolamine
Dosage: 10 mg, unk
Administration route: Oral
Indication: Irritable Bowel Syndrome
Start date: 2011-05-20
Clozaril
Dosage: unk mg, unk
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-08-09
Risperidone
Dosage: unk
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Sertraline Hydrochloride; Ferrous Sulfate TAB; Hyoscine Hydrobromide
Possible Scopolamine side effects in 44 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-11-02
Patient: 44 year old male, weighing 74.4 kg (163.7 pounds)
Reactions: White Blood Cell Count Decreased, Weight Decreased, Vomiting, Persecutory Delusion, Hallucination, Auditory, Microcytic Anaemia, RED Blood Cell Elliptocytes Present, Ideas of Reference, Dizziness, Platelet Count Decreased, Salivary Hypersecretion, Neutropenia
Drug(s) suspected as cause:
Clozaril
Clozaril
Administration route: Oral
Start date: 2010-08-09
End date: 2011-05-20
Clozaril
Administration route: Oral
Indication: Schizophrenia
Start date: 2010-08-09
End date: 2011-05-20
Risperidone
Indication: Product Used FOR Unknown Indication
Scopolamine
Administration route: Oral
Indication: Irritable Bowel Syndrome
End date: 2011-05-20
Other drugs received by patient: Hyoscine Hydrobromide; Sertraline Hydrochloride; Ferrous Sulfate TAB
Possible Scopolamine side effects in 44 year old male
Reported by a physician on 2011-11-01
Patient: 44 year old male, weighing 74.4 kg (163.7 pounds)
Reactions: Weight Decreased, Hallucination, Auditory, RED Blood Cell Target Cells Present, Mean Cell Volume Decreased, Microcytic Anaemia, Iron Deficiency Anaemia, Ideas of Reference, Dizziness, Salivary Hypersecretion, White Blood Cell Count Decreased, Vomiting, Persecutory Delusion, General Physical Health Deterioration, Seasonal Allergy, RED Blood Cell Elliptocytes Present, Platelet Count Decreased, Blood Smear Test Abnormal, Neutropenia
Drug(s) suspected as cause:
Scopolamine
Dosage: (10 mg),oral
Administration route: Oral
Indication: Irritable Bowel Syndrome
Clozaril
Dosage: (400 mg),oral ; (375 mg),oral
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-08-09
Clozaril
Dosage: (400 mg),oral ; (375 mg),oral
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
End date: 2011-05-20
Risperidone
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Ferrous Sulfate TAB; Hyoscine Hydrobromide (Hyoscnie Hydrobromide); Sertraline Hydrochloride
Possible Scopolamine side effects in 44 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-10-31
Patient: 44 year old male, weighing 74.4 kg (163.7 pounds)
Reactions: Weight Decreased, White Blood Cell Count Decreased, Persecutory Delusion, Vomiting, Hallucination, Auditory, Mean Cell Volume Decreased, Microcytic Anaemia, RED Blood Cell Elliptocytes Present, Seasonal Allergy, Ideas of Reference, Platelet Count Decreased, Dizziness, Neutropenia, Salivary Hypersecretion
Drug(s) suspected as cause:
Clozaril
Administration route: Oral
Indication: Schizophrenia, Paranoid Type
Start date: 2010-08-09
Risperidone
Indication: Product Used FOR Unknown Indication
Clozaril
Administration route: Oral
End date: 2011-05-19
Scopolamine
Administration route: Oral
Indication: Irritable Bowel Syndrome
End date: 2011-05-20
Other drugs received by patient: Hyoscine Hydrobromide; Ferrous Sulfate TAB; Sertraline Hydrochloride
Possible Scopolamine side effects in 44 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-10-26
Patient: 44 year old male, weighing 74.4 kg (163.7 pounds)
Reactions: White Blood Cell Count Decreased, Weight Decreased, Vomiting, Persecutory Delusion, Hallucination, Auditory, RED Blood Cell Target Cells Present, Microcytic Anaemia, RED Blood Cell Elliptocytes Present, Seasonal Allergy, Iron Deficiency Anaemia, Ideas of Reference, Platelet Count Decreased, Salivary Hypersecretion, Neutropenia
Drug(s) suspected as cause:
Scopolamine
Dosage: 10 mg, oral
Administration route: Oral
Indication: Irritable Bowel Syndrome
Risperidone
Indication: Product Used FOR Unknown Indication
Clozaril
Dosage: 400 mg, oral
Indication: Schizophrenia
Other drugs received by patient: Ferrous Suphate (Ferrous Sulfate); Hyoscine Hydrobromide (Hyoscine Hydrobromide); Sertraline Hydrochloride
|